Credit Crunch Squeezes "Safe" Investments

Recs

2

Where can panicked investors turn when their equity funds are in free fall and uncertainty seems to be the order of the day?

Well, scores of investors have taken refuge in short-term bond funds and money market funds in recent months, as anxiety over the market's direction has taken hold. Inflows into lower-risk money market funds have risen sharply, with assets reaching a record $3.51 trillion. But the notion that funds like these are immune from market losses and liquidity concerns is being put to the test.

A double whammy
One such ultra-short bond fund, the Schwab YieldPlus Fund, has found itself caught in a death spiral in recent weeks. The fund is designed to act like a money market fund, but it seeks to enhance returns by investing in bonds with a slightly longer duration and a higher yield. Unfortunately, the credit crunch that has roiled financial markets has also burned this Charles Schwab (Nasdaq: SCHW) fund. As the value of the fund's assets has dropped, investors have begun pulling out money, afraid of further losses. The fund's asset base has fallen from $13 billion last May to just $2.5 billion at the end of March. So far this year, the fund has fallen more than 15%.

And this isn't an isolated case. Legg Mason (NYSE: LM) recently announced that it's taking a $195 million charge to bail out one of its money market funds. Legg Mason is just one of a growing list of asset managers that have been forced to step in and aid faltering money market funds in recent months, including Credit Suisse (NYSE: CS), Janus Capital (NYSE: JNS), and Wells Fargo (NYSE: WFC).

Investors can take away two important lessons from these events. First, even "safe" investments can lose money, and in certain environments, they can lose a lot of money. Even money market funds can run into problems -- we've seen ample evidence of that lately. Don't assume that a low-risk investment means no risk. There is no free lunch in investing, and you never get something for nothing.

Second, this is unlikely to be the last of the bailouts we will see in this sector. The credit squeeze will claim many more victims before it's all over. So don't be surprised to hear about more managers having to shore up their funds. We're not out of the woods yet, so brace yourself for more charges, writedowns, and downside surprises in the financial sector -- even in so-called "safe" investments.

Related articles:

Closed for 15 months – opening 10 days only! Get notified ahead of time as our expert portfolio manager invests $1 MILLION in the best opportunities from across The Motley Fool’s premium investment services. This is the first open since August 2008, by invitation only. Enter email below.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 613399, ~/Articles/ArticleHandler.aspx, 11/10/2009 7:31:58 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Health-Care Reform: A Tale of Two Chambers

Related Tickers

11/9/2009 4:01 PM
JNS $13.98 Up +0.66 +4.96%
Janus Capital Grou… CAPS Rating: ***
LM $31.60 Up +1.40 +4.64%
Legg Mason, Inc. CAPS Rating: ****
WFC $28.40 Up +1.28 +4.72%
Wells Fargo & Comp… CAPS Rating: ***
SCHW $17.83 Up +0.70 +4.09%
The Charles Schwab… CAPS Rating: ****

Community: Investing Wiki

Term Of The Hour

Biotechnology: Biotechnology uses biological processes to solve problems in such areas as health and medicine, agriculture and manufacturing.

Want to learn more or edit this definition?
Click here to read more!